Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2017
Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled StudyFrancisco J Blanco, Rüdiger Möricke, Eva Dokoupilova, et al.
Rheumatology and Therapy|August 20, 2018
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 StudyAlan J Kivitz, Ulf Wagner, Eva Dokoupilova, et al.
Expert Opinion on Biological Therapy|April 23, 2026
Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group studyHonghu Tang, Eva Dokoupilova, Bogdan Batko, et al.
Arthritis Research & Therapy|December 24, 2017
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3Karel Pavelka, Alan Kivitz, Eva Dokoupilova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 14, 2018
Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis: Fifty-Two-Week Phase III Randomized Study ResultsMichael E Weinblatt, Asta Baranauskaite, Eva Dokoupilova, et al.
Rheumatology (Oxford, England)|June 11, 2020
An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritisJean-Pierre Pelletier, Jean-Pierre Raynauld, Marc Dorais, et al.
The Journal of Dermatological Treatment|May 17, 2017
Efficacy and safety of etanercept in psoriasis and psoriatic arthritis in the PRESTA study: analysis in patients from Central and Eastern EuropeNemanja Damjanov, Sarolta Karpati, Lajos Kemeny, et al.
Rheumatology (Oxford, England)|November 3, 2021
Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trialFrank Behrens, Philipp Sewerin, Eugenio de Miguel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 27, 2017
Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid ArthritisMichael E Weinblatt, Asta Baranauskaite, Jaroslaw Niebrzydowski, et al.
Cartilage|May 24, 2017
Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical TrialLaszlo Hangody, Robert Szody, Piotr Lukasik, et al.
Pageof 3